These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8187896)

  • 1. Hyporesponsiveness of murine myeloid progenitor cells to glucan following its repeated administration.
    Pospísil M; Vacek A; Hofer M; Viklická S; Pipalová I; Sandula J
    Folia Biol (Praha); 1993; 39(4):178-87. PubMed ID: 8187896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
    Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
    Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of in vivo administration of adamantylamide dipeptide on bone marrow granulocyte-macrophage hemopoietic progenitor cells (GM-CFC) and on ability of serum of the treated mice to stimulate GM-CFC colony formation in vitro: comparison with muramyl dipeptide and glucan.
    Vacek A; Hofer M; Masek K
    Immunopharmacol Immunotoxicol; 1999 Feb; 21(1):1-14. PubMed ID: 10084327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemopoietic effects of intravenous soluble glucan administration.
    Patchen ML; MacVittie TJ
    J Immunopharmacol; 1986; 8(3):407-25. PubMed ID: 3760593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucan-induced hemopoietic and immune stimulation: therapeutic effects in sublethally and lethally irradiated mice.
    Patchen ML; MacVittie TJ; Brook I
    Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):151-5. PubMed ID: 3713378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor.
    Patchen ML; MacVittie TJ; Solberg BD; Souza LM
    Exp Hematol; 1990 Oct; 18(9):1042-8. PubMed ID: 1697806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro.
    Lin H; She YH; Cassileth BR; Sirotnak F; Cunningham Rundles S
    Int Immunopharmacol; 2004 Jan; 4(1):91-9. PubMed ID: 14975363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of hematopoietic recovery in gamma-irradiated mice by the joint use of diclofenac, an inhibitor of prostaglandin production, and glucan, a macrophage activator.
    Pospísil M; Hofer M; Pipalová I; Viklická S; Netíková J; Sandula J
    Exp Hematol; 1992 Aug; 20(7):891-5. PubMed ID: 1628707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
    Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
    Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effect of orally administered soluble beta-(1-3),(1-6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis.
    Harnack U; Eckert K; Fichtner I; Pecher G
    In Vivo; 2010; 24(1):59-63. PubMed ID: 20133977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of hematopoietic progenitor cells by yeast-derived beta-glucan requires activation of matrix metalloproteinase-9.
    Cramer DE; Wagner S; Li B; Liu J; Hansen R; Reca R; Wu W; Surma EZ; Laber DA; Ratajczak MZ; Yan J
    Stem Cells; 2008 May; 26(5):1231-40. PubMed ID: 18339771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
    Yeager AM; Levin FC; Levin J
    J Cell Physiol; 1982 Aug; 112(2):222-8. PubMed ID: 7119022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic recovery in repeatedly irradiated mice can be enhanced by a repeatedly administered combination of diclofenac and glucan.
    Hofer M; Pospísil M; Viklická S; Vacek A; Pipalová I; Bartonícková A
    J Leukoc Biol; 1993 Feb; 53(2):185-9. PubMed ID: 8445330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of murine splenic granulocyte-macrophage colony-forming cells to lipid A in vivo.
    Mergenthaler HG; Staber FG; Hültner L; Dörmer P
    Exp Hematol; 1982 Sep; 10(8):637-49. PubMed ID: 7140866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
    Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
    Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
    van Os R; Robinson S; Sheridan T; Mauch PM
    Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glucan on granulopoiesis and macrophage genesis in mice.
    Burgaleta C; Golde DW
    Cancer Res; 1977 Jun; 37(6):1739-42. PubMed ID: 300652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postirradiation glucan administration enhances the radioprotective effects of WR-2721.
    Patchen ML; MacVittie TJ; Jackson WE
    Radiat Res; 1989 Jan; 117(1):59-69. PubMed ID: 2536480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.